Radiation Esophagitis Mimicking Disease Progression on FAPI PET/CT: Time to Re-evaluate FAPI in Response Evaluation?
68 Ga- Fibroblast activation protein inhibitor (FAPI) positron emission tomography/computed tomography (PET/CT) is increasingly used in oesophageal cancer staging and response assessment. However, radiation-induced inflammatory changes can cause false-positive tracer uptake, mimicking disease progression. We report a case of post-chemoradiotherapy radiation esophagitis resulting in diffuse oesophageal FAPI uptake with discordant CT findings. This case highlights the importance of correlating tracer uptake with structural CT findings and clinical context.
Authors
- Nisha T. Vishnu
- Suraj Kumar (ORCID: https://orcid.org/0000-0003-3724-3770)
- S S Nayak (ORCID: https://orcid.org/0000-0002-1393-0341)
- Gayana Shankaramurthy
- Suresh MC Babu
Institutions
- Kempegowda Institute of Medical Sciences (IN)
- Krishna Institute of Medical Sciences (IN)
- Karnataka Institute of Medical Sciences (IN)
Publication Details
- Journal
- Indian Journal of Nuclear Medicine
- Published
- 2026-11-17
- DOI
- https://doi.org/10.25259/ijnm_131_2026
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00